Healthcare provider profile · identity verified

Rowsonara Akhter, M.D.

Internal Medicine · STRATFORD, NJ · NPI 1477844421

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	361	92
Amlodipine Besylate	Amlodipine Besylate	273	71
Gabapentin	Gabapentin	229	65
Albuterol Sulfate Hfa	Albuterol Sulfate	220	71
Losartan Potassium	Losartan Potassium	211	59
Metformin Hcl	Metformin Hcl	201	63
Omeprazole	Omeprazole	166	52
Rosuvastatin Calcium	Rosuvastatin Calcium	138	38
Pantoprazole Sodium	Pantoprazole Sodium	134	40
Sertraline Hcl	Sertraline Hcl	126	24
Lisinopril	Lisinopril	122	39
Levothyroxine Sodium	Levothyroxine Sodium	109	26
Zolpidem Tartrate	Zolpidem Tartrate	108	17
Montelukast Sodium	Montelukast Sodium	106	32
Tamsulosin Hcl	Tamsulosin Hcl	100	30
Tramadol Hcl	Tramadol Hcl	99	22
Famotidine	Famotidine	98	34
Januvia	Sitagliptin Phosphate	90	23
Alprazolam	Alprazolam	85	13
Prednisone	Prednisone	84	60
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	82	27
Carvedilol	Carvedilol	80	20
Furosemide	Furosemide	80	28
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	78	20
Metoprolol Tartrate	Metoprolol Tartrate	74	19
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	72	17
Jardiance	Empagliflozin	68	15
Meloxicam	Meloxicam	68	23
Glimepiride	Glimepiride	67	17
Metformin Hcl Er	Metformin Hcl	65	16
Tradjenta	Linagliptin	62	11
Metoprolol Succinate	Metoprolol Succinate	61	20
Olanzapine	Olanzapine	61	13
Ozempic	Semaglutide	60	12
Pravastatin Sodium	Pravastatin Sodium	60	17
Mirtazapine	Mirtazapine	59	18
Buspirone Hcl	Buspirone Hcl	55	14
Duloxetine Hcl	Duloxetine Hcl	55	19
Azithromycin	Azithromycin	53	41
Hydrochlorothiazide	Hydrochlorothiazide	53	20
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	53	16
Farxiga	Dapagliflozin Propanediol	50	17
Trazodone Hcl	Trazodone Hcl	50	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	44	14
Quetiapine Fumarate	Quetiapine Fumarate	44	11
Ibuprofen	Ibuprofen	43	21
Methylprednisolone	Methylprednisolone	42	20
Oxycodone Hcl	Oxycodone Hcl	42	suppressed
Simvastatin	Simvastatin	41	13
Doxycycline Hyclate	Doxycycline Hyclate	40	34
Escitalopram Oxalate	Escitalopram Oxalate	40	12
Fluticasone Propionate	Fluticasone Propionate	37	20
Ketoconazole	Ketoconazole	37	14
Clopidogrel	Clopidogrel Bisulfate	36	13
Esomeprazole Magnesium	Esomeprazole Magnesium	35	suppressed
Diclofenac Sodium	Diclofenac Sodium	34	18
Spironolactone	Spironolactone	34	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	33	13
Irbesartan	Irbesartan	32	suppressed
Repaglinide	Repaglinide	31	suppressed
Breo Ellipta	Fluticasone/Vilanterol	30	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	30	suppressed
Levetiracetam	Levetiracetam	30	suppressed
Alendronate Sodium	Alendronate Sodium	29	suppressed
Donepezil Hcl	Donepezil Hcl	29	suppressed
Hydralazine Hcl	Hydralazine Hcl	29	12
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	28	24
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	28	11
Vascepa	Icosapent Ethyl	28	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	27	suppressed
Risperidone	Risperidone	27	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	26	11
Citalopram Hbr	Citalopram Hydrobromide	25	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	25	15
Linzess	Linaclotide	25	suppressed
Lorazepam	Lorazepam	25	suppressed
Meclizine Hcl	Meclizine Hcl	25	15
Ondansetron Hcl	Ondansetron Hcl	24	15
Oxybutynin Chloride	Oxybutynin Chloride	24	suppressed
Hydroxyzine Pamoate	Hydroxyzine Pamoate	23	suppressed
Telmisartan	Telmisartan	22	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	21	20
Clonidine Hcl	Clonidine Hcl	21	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	21	suppressed
Valsartan	Valsartan	21	suppressed
Breztri Aerosphere	Budesonide/Glycopyr/Formoterol	20	suppressed
Ezetimibe	Ezetimibe	20	suppressed
Mupirocin	Mupirocin	20	16
Atenolol	Atenolol	19	suppressed
Bydureon Bcise	Exenatide Microspheres	19	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	19	17
Oxybutynin Chloride Er	Oxybutynin Chloride	19	suppressed
Tizanidine Hcl	Tizanidine Hcl	19	suppressed
Valacyclovir	Valacyclovir Hcl	19	suppressed
Aripiprazole	Aripiprazole	18	11
Eliquis	Apixaban	18	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	18	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	18	11
Pregabalin	Pregabalin	18	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	18	suppressed
Atenolol-Chlorthalidone	Atenolol/Chlorthalidone	17	suppressed
Bupropion Hcl Sr	Bupropion Hcl	17	suppressed
Clonazepam	Clonazepam	17	suppressed
Glipizide Er	Glipizide	17	suppressed
Naproxen	Naproxen	17	13
Symbicort	Budesonide/Formoterol Fumarate	17	suppressed
Topiramate	Topiramate	17	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	17	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	17	suppressed
Glipizide	Glipizide	16	suppressed
Icosapent Ethyl	Icosapent Ethyl	16	suppressed
Celecoxib	Celecoxib	15	suppressed
Steglatro	Ertugliflozin Pidolate	15	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	15	suppressed
Colchicine	Colchicine	14	suppressed
Janumet	Sitagliptin Phos/Metformin Hcl	14	suppressed
Ofloxacin	Ofloxacin	14	11
Propranolol Hcl	Propranolol Hcl	14	suppressed
Cephalexin	Cephalexin	13	suppressed
Chlorthalidone	Chlorthalidone	13	suppressed
Hydrocortisone	Hydrocortisone	13	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	13	suppressed
Nystatin	Nystatin	13	suppressed
Ropinirole Hcl	Ropinirole Hcl	13	suppressed
Memantine Hcl	Memantine Hcl	12	suppressed
Nifedipine Er	Nifedipine	12	suppressed
Ventolin Hfa	Albuterol Sulfate	12	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	11	suppressed
Ultra-Fine Nano Pen Needle	Pen Needle, Diabetic	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error